
Clinical Trials Solutions sp. z o.o.
Other data processing, hosting and related activities
Overview
Clinical Trials Solutions supports clinical research through three business lines: launching and developing clinical research centers, providing financial controlling and the SMARTrials® platform to center owners, and offering operational support, recruitment, and project coordination to sponsors and CROs. Its services span strategy, implementation, and day-to-day operations.
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $0 |
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 94 days for 2021).
- 202520/07/2026
- 202425/06/2025
- 202310/07/2024
- 202216/07/2023
- 202117/10/2022
- 202006/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Clinical trial site launch
- Clinical trial site development
- Financial controlling
- Clinical trial management platform
- Clinical trial operations support
- Research participant recruitment
- Clinical project coordination
Websites
The site is available in: Polish, English and German.
- ctsolutions.euClinicals Trials Solutions – zintegrowana platforma do zarządzania badaniami klinicznymiGoogle AnalyticsGoogle Tag ManagerApache
Public procurement
3 tenders recorded as contractor: 2 national ($336,574) and 1 EU ($148,035).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Jul 21, 2026 | “Purchase of ICT, quality management and other systems supporting the management of clinical trials, including: a clinical trial management system and a feasibility study system” under the project “Centrum Wsparcia Badań Klinicznych dla Mazowsza Zachodniego”. | $148K$148,035 | Mazowieckie Centrum Leczenia Chorób Płuc I Gruźlicy | |
| Apr 17, 2026 | Purchase and implementation of an integrated IT system for managing clinical trials under the project “Centrum Wsparcia Badań Klinicznych dla Mazowsza Zachodniego” | $182.6K$182,604 | Centrum Zdrowia Mazowsza Zachodniego sp. z o.o. | |
| Apr 18, 2023 | ZP/2/2023 - Service for the design, implementation, provision of warranty service and supervision, and support of the IT system for Onkologiczne Centrum Wsparcia Badań Klinicznych Instytutu „CZMP” | $154K$153,971 | Instytut Centrum Zdrowia Matki Polki |
The company is the contractor in one public sector contract, worth USD 23.01k.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Sep 2, 2026 | Educational and Consultation Platform | $23,015 | Uniwersytet Medyczny w Lublinie |
Clinical Trials Solutions has been a party to 4 cases before the National Appeal Chamber (since 2022). In 1 case it joined the proceedings as a participant.
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| Dec 8, 2025 | Appeal | Discontinued | Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy w Warszawie | |
| Mar 6, 2023 | Abnormally low price | Upheld | Instytut "Centrum Zdrowia Matki Polki" | |
| Feb 24, 2023 | Tender | Discontinued | Świętokrzyskie Centrum Onkologii w Kielcach |
Trademarks
The company holds 2 active trademarks registered with the Polish Patent Office. The first mark was filed in 2018.
| Mark | Number | Classes | Status | Protected until | |
|---|---|---|---|---|---|
| SMARTrials (word) | Z.483426 | 9 | Protected | Mar 13, 2028 | |
| SMARTrials | Z.483427 | 9 | Protected | Mar 13, 2028 |
| Mark | Protected until | |
|---|---|---|
| SMARTrials (word) | Mar 13, 2028 | |
| SMARTrials | Mar 13, 2028 |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the President of the Management Board acts independently. In the case of a multi-member management board, the company shall be represented by the President of the Management Board acting independently, or by two members of the management board acting jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 231 | $3,119.94 | 33.3333% | |
Marek Konieczny age 56 | 231 | $3,119.94 | 33.3333% |
Stanisław Pisarski age 66 | 231 | $3,119.94 | 33.3333% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-03-01.
78 1050 1722 1000 0090 8033 9550
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 4,946PLN 4,946 |
Public aid
7 public aid cases recorded, with a total value of $146,030.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 27, 2022 | Other crisis aid | $16,601$16,601 | Tarnowska Agencja Rozwoju Regionalnego S.A. | |
| Jun 27, 2022 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $3,971$3,971 | Tarnowska Agencja Rozwoju Regionalnego S.A. | |
| Sep 21, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $115.4K$115,391 | Tarnowska Agencja Rozwoju Regionalnego S.A. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MDR Regulator sp. z o.o. | $377,079.69 | pureclinical.eu | ||
| CCTS sp. z o.o. | $281,193.31 | ccts.pl | ||
| Genelytica sp. z o.o. | $213,207.91 | genelytica.pl | ||
| IMP Baprol sp. z o.o. | $196,258.80 | impbaprol.com | ||
| Monipol Biotech Pl sp. z o.o. | $191,735.74 | monipol-biotech.com | ||
| GCP-Service International Ltd. & Co. Kg Branch (foreign co.) | $159,376.34 | gcp-service.com | ||
| Pharmaxi Poland sp. z o.o. | $152,292.34 | pharmaxi.com.ua | ||
| Clinbit sp. z o.o. | $114,041.47 | clinbit.com | ||
| Prophase sp. z o.o. | $80,481.99 | prophase.eu | ||
| Elligo Labs sp. z o.o. | $40,080.36 | elligo.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-07-10 | Share capital increase (24,250.00 PLN → 34,650.00 PLN) | |
| 2025-05-23 | Address change (Pl. Dworcowy 4, 33-100, Tarnów → Złota 75a/7, 00-819, Warszawa) | |
| 2025-05-23 | Share capital increase (23,500.00 PLN → 24,250.00 PLN) | |
| 2025-05-23 | Switch to PKD 2025 (6 PKD 2007 codes → 9 PKD 2025 codes) | |
| 2019-04-16 | Share capital increase (20,000.00 PLN → 23,500.00 PLN) |
FAQ
Last updated: 2026-07-20